Disclosed are compounds of formulas (I)-(IX) for treating or preventing a disease or disorder responsive to antagonism of a P2Y.sub.14R receptor agonist in a mammal in need thereof, wherein R.sup.1-R.sup.8, X, Y, Z, X′, Y′, Z′, and A are as defined herein, that are useful in treating an inflammatory such as asthma, cystic fibrosis, and sterile inflammation of the kidney. ##STR00001##

Disclosed are compounds of formulas (I)-(IX) for treating or preventing a disease or disorder responsive to antagonism of a P2Y.sub.14R receptor agonist in a mammal in need thereof, wherein R.sup.1-R.sup.8, X, Y, Z, X′, Y′, Z′, and A are as defined herein, that are useful in treating an inflammatory such as asthma, cystic fibrosis, and sterile inflammation of the kidney. ##STR00001##

The present disclosure relates to an organic electroluminescent compound and an organic electroluminescent device comprising the same. The organic electroluminescent device having a low driving voltage and/or a high luminous efficiency and/or a long lifespan can be provided, by comprising an organic electroluminescent compound according to the present disclosure.

The present disclosure relates to an organic electroluminescent compound and an organic electroluminescent device comprising the same. The organic electroluminescent device having a low driving voltage and/or a high luminous efficiency and/or a long lifespan can be provided, by comprising an organic electroluminescent compound according to the present disclosure.

The present disclosure provides, inter alia, compounds with MASP-2 inhibitory activity, compositions of such compounds and methods of making and using such compounds.

The present disclosure provides, inter alia, compounds with MASP-2 inhibitory activity, compositions of such compounds and methods of making and using such compounds.

The present disclosure provides a nitrogen-containing compound, an organic electroluminescent device and an electronic apparatus, belonging to the technical field of organic materials. The nitrogen-containing compound of the present disclosure has a carbazole structure and a fluorenyl group, two cooperating with each other and has a high first triplet energy level. Therefore, the nitrogen-containing compound of the present disclosure is suitable for use as a host material of a light-emitting in an organic electroluminescent device. The nitrogen-containing compound can improve the performance of the organic electroluminescent device.

To provide a compound that further improves the capability of an organic EL device, an organic EL device having a further improved device capability, and an electronic device including the organic EL device. A compound represented by the following formula (1) (wherein *p, *q, *r, *s, *b, *a, R.sup.1, R.sup.2, R.sup.11 to R.sup.18, L, and R.sup.31 to R.sup.35 are defined in the description), an organic electroluminescent device containing the compound, and an electronic device including the organic electroluminescent device.

##STR00001##

To provide a compound that further improves the capability of an organic EL device, an organic EL device having a further improved device capability, and an electronic device including the organic EL device. A compound represented by the following formula (1) (wherein *p, *q, *r, *s, *b, *a, R.sup.1, R.sup.2, R.sup.11 to R.sup.18, L, and R.sup.31 to R.sup.35 are defined in the description), an organic electroluminescent device containing the compound, and an electronic device including the organic electroluminescent device.

##STR00001##

The present technology provides aryl or heteroaryl triazolone derivatives or pharmaceutically acceptable salts thereof, preparation processes thereof, pharmaceutical compositions comprising the same, and the use thereof. The aryl or heteroaryl triazolone derivatives or their pharmaceutically acceptable salts exhibit selective inhibitory activity on VAP-1 and therefore can be usefully applied, e.g., for the treatment and prophylaxis of nonalcoholic hepatosteatosis (NASH).